Key Takeaways
- Fatty liver disease occurs when excess fat accumulates in the liver, impairing metabolic function.
- Nearly 80 million Americans have fatty liver disease, a number similar to those with pre-diabetes.
- Insulin resistance is a major underlying driver of the condition.
- There are currently no approved drugs specifically designed to treat fatty liver disease.
- Increasing AMPK activity helps the body burn stored fat in the liver.
- Metabolic Engineering® combines the Zone diet, omega-3 fatty acids, and polyphenols to address the metabolic causes of fatty liver disease.
What Is Fatty Liver Disease?
Fatty liver disease occurs when excess fat accumulates in the liver and begins to interfere with normal metabolic function. Over time, this buildup can lead to inflammation, liver damage, and broader metabolic complications.
Fatty liver disease is becoming increasingly common. Nearly 80 million Americans currently have the condition (1). This number closely mirrors the number of Americans with pre-diabetes, which is not surprising since both conditions are strongly linked to insulin resistance (2).
When insulin resistance increases, the body becomes less efficient at managing blood sugar and fat metabolism. As a result, fat can accumulate in tissues such as the liver
The Two Types of Fatty Liver Disease
Fatty liver disease is generally classified into two main categories:
Alcohol-Induced Fatty Liver Disease
This form develops from excessive alcohol consumption, which disrupts normal liver metabolism and leads to fat accumulation in liver cells.
Traditional recommendation:
Stop drinking alcohol to allow the liver to recover.
Metabolic (Non-Alcoholic) Fatty Liver Disease
This form is driven primarily by insulin resistance and metabolic dysfunction rather than alcohol intake.
Traditional recommendation:
Lose weight through diet and lifestyle changes.
Currently, there are no approved drugs specifically designed to treat either type of fatty liver disease.
The Metabolic Engineering® Approach to Fatty Liver Disease
Because fatty liver disease is closely linked to insulin resistance and metabolic dysfunction, addressing the underlying metabolic imbalance is critical.
Metabolic Engineering® focuses on increasing the activity of AMPK, a key metabolic regulator that helps control how the body burns fat for energy.
When AMPK activity increases, the liver becomes more efficient at oxidizing stored fat, helping reduce fat accumulation in liver tissue (2).
Metabolic Engineering® addresses fatty liver disease through three primary dietary components:
1. The Zone Diet
The Zone diet helps activate AMPK by creating mild calorie restriction without hunger or fatigue. This metabolic balance helps the body burn stored fat more efficiently.
2. Omega-3 Fatty Acids
Omega-3 fatty acids help reduce inflammation and promote the repair of damaged liver tissue. They also act as indirect activators of AMPK, further supporting improved metabolic function.
3. Polyphenols
Dietary polyphenols help reduce oxidative stress, a key contributor to liver damage in fatty liver disease. Like omega-3 fatty acids, polyphenols also indirectly support AMPK activation, making dietary strategies such as the Zone diet more effective (3).
Together, these strategies help address the metabolic causes of fatty liver disease rather than simply treating symptoms.
For more content on Liver Disease, click here
References
1. Cotter TG, Rinella M. Gastroenterology. Nonalcoholic fatty liver disease 2020: The state of the disease. 2020; 158:1851-1864. doi:10.1053/j.gastro.2020.01.052.
2. Fang C, Pan J, Qu N, Lei Y, Han J, Zhang J, Han D. The AMPK pathway in fatty liver disease. Front Physiol. 2022; 13:970292. doi: 10.3389/fphys.2022.970292.
3. Sears B and Saha AK. Dietary control of inflammation and resolution.Front Nutr. 2021; 8:709435. doi: 10.3389/fnut.2021.709435.
